We are live on ! Find out more
LCTX icon

Lineage Cell Therapeutics

109 hedge funds and large institutions have $151M invested in Lineage Cell Therapeutics in 2017 Q2 according to their latest regulatory filings, with 20 funds opening new positions, 36 increasing their positions, 21 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

186% more first-time investments, than exits

New positions opened: 20 | Existing positions closed: 7

71% more repeat investments, than reductions

Existing positions increased: 36 | Existing positions reduced: 21

14% more funds holding

Funds holding: 96109 (+13)

1.33% more ownership

Funds ownership: 48.18%49.51% (+1.3%)

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

6% less capital invested

Capital invested by funds: $161M → $151M (-$9.93M)

27% less call options, than puts

Call options by funds: $112K | Put options by funds: $153K

Holders
109
Holders Change
+13
Holders Change %
+13.54%
% of All Funds
2.72%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.02%
New
20
Increased
36
Reduced
21
Closed
7
Calls
$112K
Puts
$153K
Net Calls
-$41K
Net Calls Change
+$59K